The C18 dibenzocyclooctadiene lignans including three novel schizanrin F (1), G (2), H (3), along with the known kadsurarin (4), were isolated from Kadsura matsudai. A new C19 homolignan named schiarisanrin E (5), together with the known C18 lignans, gomisin B (6), G (7) and (+)-gomisin K3 (8) were obtained from Schizandra arisanensis. Gomisin B, G and (+)-gomisin K3 showed moderate to strong activity for antihepatitis in anti-HBsAg (human type B hepatitis, surface antigen) and/or anti-HBeAg (human type B hepatitis, e antigen) tests. The structural elucidations of new compounds 1 - 3 and 5 were based on two-dimensional (2D) NMR techniques including COSY, HMQC, HMBC, NOESY and CD spectra. Preliminary structure-activity relationship studies for these isolated lignans are also discussed. © 2003 Pharmaceutical Society of Japan.
CITATION STYLE
Wu, M. D., Huang, R. L., Kuo, L. M. Y., Hung, C. C., Ong, C. W., & Kuo, Y. H. (2003). The anti-HBsAg (human type B hepatitis, surface antigen) and anti-HBeAg (human type B hepatitis, e antigen) C18 dibenzocyclooctadiene lignans from Kadsura matsudai and Schizandra arisanensis. Chemical and Pharmaceutical Bulletin, 51(11), 1233–1236. https://doi.org/10.1248/cpb.51.1233
Mendeley helps you to discover research relevant for your work.